IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology

Autor: Colin L. Noble, Nikolas Plevris, Ian D. Arnott, Philip Jenkinson, David C. Wilson, Cathy Bisset, C Burgess, Charlie W. Lees, Shahida Din, Gareth-Rhys Jones, Paul Henderson, Gwo-Tzer Ho, James Fulforth, Kathryn Kirkwood, Alan G. Shand, Mathew Lyons
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Gut
Jones, G-R, Lyons, M, Plevris, N, Jenkinson, P W, Bisset, C, Burgess, C, Din, S, Fulforth, J, Henderson, P, Ho, G-T, Kirkwood, K, Noble, C, Shand, A G, Wilson, D C, Arnott, I DR & Lees, C W 2019, ' IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology ', Gut, vol. 68, no. 11, pp. 1953-1960 . https://doi.org/10.1136/gutjnl-2019-318936
ISSN: 1468-3288
0017-5749
DOI: 10.1136/gutjnl-2019-318936
Popis: ObjectiveIBD prevalence is estimated to be rising, but no detailed, recent UK data are available. The last reported prevalence estimate in the UK was 0.40% in 2003. We aimed to establish the current, and project future, prevalence in Lothian, Scotland.DesignWe conducted an all-age multiparameter search strategy using inpatient IBD international classification of disease (ICD-10) coding (K50/51)(1997–2018), IBD pathology coding (1990–2018), primary and secondary care prescribing data (2009–2018) and a paediatric registry, (1997–2018) to identify ‘possible’ IBD cases up to 31/08/2018. Diagnoses were manually confirmed through electronic health record review as per Lennard-Jones/Porto criteria. Autoregressive integrated moving average (ARIMA) regression was applied to forecast prevalence to 01/08/2028.ResultsIn total, 24 601 possible IBD cases were identified of which 10 499 were true positives. The point prevalence for IBD in Lothian on 31/08/2018 was 784/100 000 (UC 432/100 000, Crohn’s disease 284/100 000 and IBD unclassified (IBDU) 68/100 000). Capture–recapture methods identified an additional 427 ‘missed’ cases (95% CI 383 to 477) resulting in a ‘true’ prevalence of 832/100 000 (95% CI 827 to 837).Prevalence increased by 4.3% per year between 2008 and 2018 (95% CI +3.7 to +4.9%, p80 years of age.ConclusionsWe report a rigorously validated IBD cohort with all-age point prevalence on 31/08/2018 of 1 in 125, one of the highest worldwide.
Databáze: OpenAIRE